Dogra Gupta. The SARS-CoV-2 strain (NIV-2020-770) used in developing the BBV152 vaccine is retrieved from tourists who arrive in New Delhi, India. The scientific...
28 KB (1,983 words) - 16:41, 27 July 2024
000 participants. BBIBP-CorV shares similar technology with CoronaVac and BBV152, other inactivated virus vaccines for COVID-19. Peer-reviewed results published...
17 KB (1,205 words) - 14:24, 5 July 2024
Biotech/Indian Council of Medical Research Completed Bharat Biotech's Covaxin (BBV152) is an inactivated COVID-19 vaccine that uses adjuvant Alhydroxiquim-II...
139 KB (4,697 words) - 03:30, 16 August 2024
the Serum Institute of India (SII) under the trade name "Covishield", and BBV152 (Covaxin), a vaccine developed by Bharat Biotech in association with the...
337 KB (26,335 words) - 03:11, 29 July 2024
doi:10.1038/s41573-021-00163-y. PMC 8023785. PMID 33824489. "COVAXIN® (BBV152) – Inactivated, COVID-19 vaccine". www.who.int. Retrieved 2024-07-14. Soni...
38 KB (4,272 words) - 06:58, 9 August 2024
- University of Oxford’s AZD1222 (marketed as Covishield in India) and BBV152 (marketed as Covaxin, developed in India by Bharat Biotech in association...
5 KB (335 words) - 21:24, 16 April 2024
world, and their joint product was mostly referred to simply as 'Pfizer'. BBV152 CureVac Moderna COVID-19 vaccine Novavax COVID-19 vaccine Oxford–AstraZeneca...
40 KB (3,633 words) - 02:16, 24 March 2024
convalescent sera of the COVID-19 cases and recipients of Bharat Biotech's BBV152 (Covaxin) were able to neutralise VUI B.1.617 although with a lower efficacy...
101 KB (10,984 words) - 14:46, 12 July 2024
Federal Audit Court and the Federal Public Prosecutor's Office. Covaxin (or BBV152) is a vaccine against COVID-19 produced in India by the Bharat Biotech laboratory...
15 KB (1,189 words) - 18:09, 7 November 2023